Confronting the Echoes of the Past
Walking past the gift shop at the resort where we stayed over winter break, I heard someone call out: “Everyone's talking about you.” The hotel manager leaned out, pointing out the changes in my body, suggesting my workouts had paid off. Little did she know, my “new” body bore the marks of a darker chapter of my life—a chapter I thought I had closed.
My journey began with tirzepatide, a GLP-1 medication prescribed off-label for my chronic migraines. I noted its weight-loss claims and decided that if it could help me manage migraines and improve my self-image, it was a win-win. Or so I thought.
A Fragile Balance
Upon my doctor's warning, I made a promise: I would stay aware of my calorie intake. I was aware of my history with anorexia, and I promised myself that I had healed. But as the weight dropped quickly, I found it alarmingly easy to slip back into an old mindset.
Culture and Conditioning
Living in a society that often values thinness over health, it's no wonder I began to relish the compliments that came with my weight loss. I felt deeply aware of my body, my image constantly flashing before my eyes like a frame in a film I never wanted to star in.
“It feels like they're talking about somebody else,” I told my husband. “Like this body isn't something I made myself. It feels fake, like a body on loan.”
GLP-1: A Double-Edged Sword
As I continued my GLP-1 regimen, the initial thrill of transformation began to overshadow my past. The medication provided clarity: I lost the noise of constant food calculations. Yet I now ponder the deep undertones of my happiness—was it built on an ephemeral illusion, or am I simply another woman caught in the societal rush for validation?
GLP-1s are now being marketed to a demographic of women in midlife—us, the daughters of feminism, still wrestling with beauty standards imposed by the patriarchy. We are told that these medications can facilitate a healthy lifestyle, yet they also can reignite long-buried disorders.
Facing the Fear
The moment arrived when my weight loss had transformed me back to my uncomfortable past, echoing shades of an old eating disorder. I felt caught off guard; the joy of losing weight came hand in hand with the ghosts of my previous struggles.
As I reflect on how far I've come, I see the path forward riddled with complexity. I must navigate this new terrain with intent, focusing not only on combating migraines but also fostering a healthy relationship with food and body image—a mission that seems increasingly complex in an Instagram filter-filled world.
Empowerment or Entanglement?
GLP-1s aren't universally bad—in fact, I know others who use them with great success. But as I question my motives and actions, I realize my story isn't one of an empowered journey, but rather a cautionary tale about how easy it is to regress into past demons. I must rise above and redefine my self-worth, apart from the pills and the scale.
Ultimately, I must contend with this truth: I thought I had conquered my eating disorder. Yet with each passing day on GLP-1, I noticed how flexible my perspective was becoming—and it scared me. How do we measure worth beyond weight? This is a critical question I grapple with now.
Key Facts
- Author: Alexis Barad-Cutler
- Medication Used: Tirzepatide, a GLP-1 medication
- Initial Purpose: Prescribed off-label for chronic migraines
- Personal History: History of anorexia
- Weight Loss: Lost about 20 pounds following medication
- Marketed Demographic: Women in midlife
- Personal Reflection: Struggled with self-image and societal pressures
- Cautionary Insight: Recognized potential relapse into eating disorder
Background
As GLP-1 medications are increasingly marketed for weight loss among women, there is growing concern about their impact, particularly for those with a history of eating disorders. Alexis Barad-Cutler shares her personal journey navigating these challenges while using tirzepatide for chronic migraines.
Quick Answers
- Who is Alexis Barad-Cutler?
- Alexis Barad-Cutler is a writer, founder of Not Safe For Mom Group, and author of a Substack newsletter that explores how beauty culture shapes body image.
- What medication did Alexis Barad-Cutler use?
- Alexis Barad-Cutler used tirzepatide, a GLP-1 medication, prescribed off-label for chronic migraines.
- Why did Alexis Barad-Cutler start taking GLP-1 medication?
- Alexis Barad-Cutler started taking GLP-1 medication to manage chronic migraines and noted its weight-loss claims.
- What is Alexis Barad-Cutler's personal history with eating disorders?
- Alexis Barad-Cutler has a history of anorexia and reflects on how her weight loss revived old challenges related to body image.
- What weight loss did Alexis Barad-Cutler experience?
- Alexis Barad-Cutler lost about 20 pounds while taking GLP-1 medication.
- What concerns does Alexis Barad-Cutler express about GLP-1 medications?
- Alexis Barad-Cutler expresses concerns that GLP-1 medications can reignite past eating disorders, particularly for women in midlife.
- How does Alexis Barad-Cutler feel about her weight loss?
- Alexis Barad-Cutler feels both joy and fear regarding her weight loss, reflecting on its implications for her self-worth.
- What societal pressures does Alexis Barad-Cutler discuss?
- Alexis Barad-Cutler discusses societal pressures that equate thinness with worth, complicating her relationship with body image.
Frequently Asked Questions
What is the purpose of tirzepatide?
Tirzepatide is a GLP-1 medication primarily used to treat chronic migraines off-label, while also being associated with weight loss.
Who is the target audience for GLP-1 medications?
GLP-1 medications are increasingly targeted towards women in midlife, particularly those experiencing weight gain related to menopause.
What are the risks associated with GLP-1 medications for those with eating disorders?
GLP-1 medications may trigger relapses in individuals with a history of eating disorders, particularly anorexia.
What reflections does Alexis Barad-Cutler share about her body image?
Alexis Barad-Cutler reflects on her complicated feelings regarding body image, influenced by societal standards and her personal history.
Source reference: https://www.newsweek.com/beat-eating-disorder-years-ago-then-glp1-migraines-11925265





Comments
Sign in to leave a comment
Sign InLoading comments...